Human adipose-derived mesenchymal stem cells (MSCs) have earned the spotlight for regenerative applications due to similar therapeutic potential to that of bone marrow MSCs combined with easy availability. Clinical trials have been using adipose-derived stem cells due to their advantages over other MSC sources.